In addition to these, triggering other signaling pathways downstream of cytokine receptors like NF-κβ and JAK/STAT can result in the activation of MAPK and PI3K/Akt signaling in the TME of CTCL (69, 90–92). This evidence concerns the gene NFKB1 and primary cutaneous T-cell non-Hodgkin lymphoma.